Quantcast

Latest Capecitabine Stories

2009-07-22 07:00:00

WAYNE, N.J. and EMERYVILLE, Calif., July 22 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that their first cooperative group-sponsored randomized Phase 2 trial in advanced metastatic breast cancer met its primary endpoint of progression-free survival. The study evaluated Nexavar(R) (sorafenib) tablets in combination with the oral chemotherapeutic, capecitabine, in patients with locally advanced or metastatic HER-2...

2009-06-01 07:35:00

Data demonstrates perifosine's anti-cancer activity and efficacy both as a single agent and in combination therapy QUEBEC CITY, June 1/PRNewswire-FirstCall/ - AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its partner, Keryx Biopharmaceuticals (Nasdaq: KERX), presented positive Phase 2 data on the clinical activity of perifosine (KRX-0401), an Akt-inhibitor compound for cancer, as a treatment...

2009-06-01 07:30:00

KRX-0401 + Capecitabine More Than Doubles Time to Progression and Overall Response Rate as well as Extends Overall Survival vs. Capecitabine + Placebo in Patients with 2nd or 3rd Line Metastatic Colon Cancer NEW YORK, June 1 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) yesterday announced data on the clinical activity of KRX-0401 (perifosine), the Company's Akt-inhibitor for cancer, in combination with capecitabine as a treatment for advanced colon cancer....

2009-05-31 07:30:00

KRX-0401 + Capecitabine More Than Doubled Time to Progression and Overall Response Rate as well as Extended Overall Survival vs. Capecitabine + Placebo in Patients with 2nd or 3rd Line Metastatic Colon Cancer NEW YORK, May 31 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced data on the clinical activity of KRX-0401 (perifosine), the Company's Akt-inhibitor for cancer, in combination with capecitabine as a treatment for advanced colon cancer. Abstract...

2009-05-27 15:20:02

A Singapore oncologist advises cancer patients treated with the drug capecitabine to carry a doctor's letter on the treatment if they have U.S travel plans. Dr. Eng-Huat Tan of the National Cancer Centre in Singapore, said the head and neck cancer of his 62-year-old patient had spread, but the cancer responded well to chemotherapy. To help prevent a recurrence of the cancer the patient was put on a maintenance dose of capecitabine, Tan said. Capecitabine is a common anticancer drug used in...

aad3ecfe80001999b63c54aa94f3e60d1
2009-05-27 13:45:20

The United States immigration said that a cancer patient from Singapore who traveled to the U.S. last year had missing fingerprints, which was determined to be an unusual side effect of his medication, The Associated Press reported. Authorities said the 62-year-old man, identified only as Mr. S, had been taking the medication capecitabine, or Xeloda, to treat head and neck cancer. Immigration officials asked him for his fingerprints once he arrived in the country and found that he no longer...

2009-05-18 12:20:00

ORLANDO, Fla., May 18 /PRNewswire-USNewswire/ -- Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options. At the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), researchers from the Mayo Clinic campus in Florida report that using a combination of capecitabine, vinorelbine, and trastuzumab offers a treatment option that is at least as beneficial...

2009-05-18 07:29:00

Results Will be Reported from Phase 2 Studies Evaluating KRX-0401 in Advanced Renal Cell Carcinoma, Colorectal Cancer and Gastrointestinal Stromal Tumors (GIST) NEW YORK, May 18 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that four abstracts on KRX-0401 (Perifosine), the Company's Akt-inhibitor for cancer, were accepted for presentation during poster sessions taking place at the 45th Annual Meeting of the American Society of Clinical Oncology...

2009-05-14 13:07:35

Chemotherapy in addition to the surgery or surgery and radiation improves survival among older women with breast cancer, U.S. researchers said. Corresponding author Dr. Hyman Muss of the University of North Carolina at Chapel Hill said the study was conducted with 600 women via the National Cancer Institute's Clinical Trials Cooperative Group Program. The study, published in The New England Journal of Medicine, compared a combination of chemotherapy drugs -- the standard treatment -- to a...

2009-04-28 09:30:00

Indian Oncologists Are Starting to Embrace Use of Targeted Agents Despite Their High Cost, According to a Report from Decision Resources WALTHAM, Mass., April 28 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Sanofi-Aventis' Eloxatin, Indian brand/generics (oxaliplatin) and Roche/Chugai's Xeloda, Indian brand/generics (capecitabine) will dominate the Indian colorectal cancer drug market...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.